Paragon 28, Inc. (NYSE:FNA) Receives $14.20 Consensus PT from Brokerages

Paragon 28, Inc. (NYSE:FNA) has received a consensus rating of “Hold” from the six analysts that are currently covering the stock, Marketbeat.com reports. Four analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average 1 year target price among analysts that have updated their coverage on the stock in the last year is $14.20.

A number of research analysts have recently weighed in on the company. Stephens restated an “equal weight” rating and issued a $13.00 price target (down previously from $14.00) on shares of Paragon 28 in a research report on Thursday, January 30th. Canaccord Genuity Group set a $13.00 target price on shares of Paragon 28 in a report on Wednesday, January 29th. Needham & Company LLC reaffirmed a “hold” rating and issued a $13.00 price target on shares of Paragon 28 in a report on Wednesday, January 29th. Finally, William Blair cut shares of Paragon 28 from an “outperform” rating to a “market perform” rating in a research note on Wednesday, January 29th.

Paragon 28 Stock Up 0.7 %

Shares of Paragon 28 stock opened at $13.08 on Monday. Paragon 28 has a one year low of $4.65 and a one year high of $13.13. The company has a market cap of $1.10 billion, a P/E ratio of -17.68 and a beta of 1.47. The company has a debt-to-equity ratio of 0.79, a quick ratio of 1.60 and a current ratio of 3.50. The firm has a fifty day moving average of $13.03 and a two-hundred day moving average of $10.46.

Paragon 28 (NYSE:FNA) last announced its quarterly earnings data on Thursday, March 6th. The company reported ($0.13) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.12) by ($0.01). Paragon 28 had a negative return on equity of 37.90% and a negative net margin of 25.31%. The business had revenue of $71.75 million for the quarter, compared to analyst estimates of $70.81 million. On average, analysts forecast that Paragon 28 will post -0.64 earnings per share for the current year.

Insider Buying and Selling

In other Paragon 28 news, major shareholder Mvm Partners, Llc sold 1,044,295 shares of the stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $13.04, for a total transaction of $13,617,606.80. Following the transaction, the insider now directly owns 7,810,588 shares in the company, valued at $101,850,067.52. This represents a 11.79 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Over the last 90 days, insiders have sold 1,875,984 shares of company stock worth $24,359,971. 15.32% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Paragon 28

A number of hedge funds have recently added to or reduced their stakes in FNA. Venturi Wealth Management LLC bought a new position in Paragon 28 in the fourth quarter worth about $36,000. AlphaQuest LLC raised its position in shares of Paragon 28 by 33.6% during the 4th quarter. AlphaQuest LLC now owns 3,680 shares of the company’s stock worth $38,000 after purchasing an additional 925 shares during the period. State of Wyoming raised its position in shares of Paragon 28 by 37.4% during the 4th quarter. State of Wyoming now owns 4,359 shares of the company’s stock worth $45,000 after purchasing an additional 1,187 shares during the period. GAMMA Investing LLC lifted its holdings in shares of Paragon 28 by 1,368.4% in the 1st quarter. GAMMA Investing LLC now owns 5,668 shares of the company’s stock worth $74,000 after purchasing an additional 5,282 shares during the last quarter. Finally, KLP Kapitalforvaltning AS acquired a new position in Paragon 28 during the 4th quarter valued at approximately $94,000. Institutional investors and hedge funds own 63.57% of the company’s stock.

About Paragon 28

Paragon 28, Inc develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems.